title: [Tumor lysis syndrome after transarterial embolization for hepatocellular carcinoma].
abstract: A man in his 70's was admitted to our hospital for treatment of a huge hepatocellular carcinoma (HCC) by transcatheter hepatic arterial embolization (TAE). After treatment, anuria occurred, and laboratory examinations revealed a diagnosis of tumor lysis syndrome (TLS). He underwent conservative therapy including hemodialysis, resulting in complete remission of TLS. On the other hand, poor hepatic functional reserve was seen temporarily. After conservative therapy, biochemical markers returned dramatically. TLS is a group of metabolic complications in cancer therapy. It may occur in highly sensitive tumors, resulting from a rapid release of cytoplasmic degradation products of malignant cells. Generally it is rare in the treatment of solid tumors. In the case of TAE for huge HCC, we should keep the possibility of TLS in mind.
authors: Department of Gastroenterology, Osaka City University Graduate School of Medicine, Japan.
authors: Yu
authors: Y
authors: Nishida
authors: Hideki
authors: H
authors: Fujii
authors: Atsushi
authors: A
authors: Hagihara
authors: Etsushi
authors: E
authors: Kawamura
authors: Shuji
authors: S
authors: Iwai
authors: Masaru
authors: M
authors: Enomoto
authors: Akihiro
authors: A
authors: Tamori
authors: Tetsuo
authors: T
authors: Arakawa
authors: Norifumi
authors: N
authors: Kawada
mesh_terms: D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D004621:Embolization, Therapeutic / Q000009:adverse effects*; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D006435:Renal Dialysis; D015275:Tumor Lysis Syndrome / Q000209:etiology* / Q000628:therapy